Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

ZERUST PLASTABS

STATEMENT OF HAZARDOUS NATURE

Not considered a hazardous substance according to OSHA 29 CFR 1910.1200.

NFPA

PRODUCT USE

Used in packaging as anti- corrosive to prevent rusting, corrosion, pitting. To be
effective requires to be in an enclosed space.

SYNONYMS

"Plastabs Zerust", "Zero Rust Plastabs", "corrosion inhibitor packing", "anti corrosive
packing tabs", "VPI packing Zerust"

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

None

EMERGENCY OVERVIEW

RISK

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Although ingestion is not thought to produce harmful effects, the material may still be damaging to the health of the individual following ingestion, especially where pre-  existing organ (e.g. liver, kidney) damage is evident. Present definitions of harmful or toxic substances are generally based on doses producing mortality (death) rather than those producing morbidity (disease, ill-health). Gastrointestinal tract discomfort may produce nausea and vomiting. In an occupational setting however, ingestion of insignificant quantities is not thought to be cause for concern.  Overexposure is unlikely in this form and quantity.  Considered an unlikely route of entry in commercial/industrial environments.  

EYE

  Although the material is not thought to be an irritant, direct contact with the eye may produce transient discomfort characterized by tearing or conjunctival redness (as with windburn).  Overexposure is unlikely in this form and quantity.  

SKIN

  The material is not thought to produce adverse health effects or skin irritation following contact (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting.  

INHALED

  The material is not thought to produce adverse health effects or irritation of the respiratory tract (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable control measures be used in an occupational setting.  Overexposure is unlikely in this form and quantity.  Inhalation of vapor is more likely at higher than normal temperatures.  

CHRONIC HEALTH EFFECTS

  Principal routes of exposure are usually by skin contact and  inhalation of vapour when opening closed packages.  The base material is considered to be practically non-harmful by all  exposure routes.  Additives are encapsulated in the polymer but are volatile and evolved  slowly into atmosphere.  Packages should be allowed to ventilate after opening to disperse volatiles.  As with any chemical product, ingestion in any form, prolonged or repeated  skin contact or inhalation of vapour should be avoided by good occupational  work practices.